Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

55 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Development and validation of a risk scoring model to predict net adverse cardiovascular outcomes after primary percutaneous coronary intervention in patients pretreated with 600 mg clopidogrel: rationale and design of the RISK-PCI study.
Mrdovic I, Savic L, Perunicic J, Asanin M, Lasica R, Marinkovic J, Vasiljevic Z, Ostojic M. Mrdovic I, et al. Among authors: lasica r. J Interv Cardiol. 2009 Aug;22(4):320-8. doi: 10.1111/j.1540-8183.2009.00476.x. Epub 2009 Jun 8. J Interv Cardiol. 2009. PMID: 19515084 Free article.
Incidence, predictors, and 30-day outcomes of new-onset atrial fibrillation after primary percutaneous coronary intervention: insight into the RISK-PCI trial.
Mrdovic I, Savic L, Krljanac G, Perunicic J, Asanin M, Lasica R, Antonijevic N, Kocev N, Marinkovic J, Vasiljevic Z, Ostojic M. Mrdovic I, et al. Among authors: lasica r. Coron Artery Dis. 2012 Jan;23(1):1-8. doi: 10.1097/MCA.0b013e32834df552. Coron Artery Dis. 2012. PMID: 22107800 Clinical Trial.
Impact of high post-loading platelet aggregation on 30-day clinical outcomes after primary percutaneous coronary intervention. The antiplatelet regimen tailoring after primary PCI (ART-PCI) trial.
Mrdovic I, Savic L, Krljanac G, Asanin M, Perunicic J, Antonijevic N, Lasica R, Marinkovic J, Kocev N, Vasiljevic Z. Mrdovic I, et al. Among authors: lasica r. Int J Cardiol. 2013 Aug 20;167(4):1632-7. doi: 10.1016/j.ijcard.2012.04.129. Epub 2012 May 22. Int J Cardiol. 2013. PMID: 22626838 Clinical Trial.
Usefulness of the RISK-PCI score to predict stent thrombosis in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a substudy of the RISK-PCI trial.
Mrdovic I, Savic L, Lasica R, Krljanac G, Asanin M, Brdar N, Djuricic N, Cvetinovic N, Marinkovic J, Perunicic J. Mrdovic I, et al. Among authors: lasica r. Heart Vessels. 2013 Jul;28(4):424-33. doi: 10.1007/s00380-012-0276-z. Epub 2012 Sep 14. Heart Vessels. 2013. PMID: 22975713
Simple risk algorithm to predict serious bleeding in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: RISK-PCI bleeding score.
Mrdovic I, Savic L, Krljanac G, Asanin M, Lasica R, Djuricic N, Brdar N, Marinkovic J, Kocev N, Perunicic J. Mrdovic I, et al. Among authors: lasica r. Circ J. 2013;77(7):1719-27. doi: 10.1253/circj.cj-12-1177. Epub 2013 Apr 20. Circ J. 2013. PMID: 23603843 Free article. Clinical Trial.
55 results